Bleakley Financial Group, LLC

Position in IONS — Ionis Pharmaceuticals Inc

CIK 1936953 PARSIPPANY, NJ

Position in IONS

as of Jun 30, 2026 · filed Aug 5, 2026 Compact

Position Value

$1,172,936

+$97,948 QoQ

Shares Held

14,793

+3.3% QoQ

Ownership

0.009%

of shares outstanding

% of Portfolio

0.03%

of 13F equity value

Holder Rank

#237

of 513 holders

Holding Since

Dec 2022

15 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

Bleakley Financial Group, LLC holds $23,738,174 across 21 Biotechnology names. IONS ranks #4 (4.9% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	18,400	$9,139,832
2	ANAB	Anaptysbio, Inc	42,761	$2,886,367
3	PTGX	Protagonist Therapeutics, Inc	12,538	$1,536,908
4	IONS	Ionis Pharmaceuticals Inc This page	14,793	$1,172,936
5	IBRX	ImmunityBio, Inc.	129,381	$1,132,730
6	CORT	Corcept Therapeutics Inc	11,638	$1,011,924
7	BCAX	Bicara Therapeutics Inc.	29,181	$866,383
8	RPRX	Royalty Pharma plc	14,626	$820,079

15 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$1,172,936	14,793	+3.3%	Shares	Sole	2026-08-05
2026-03-31	$1,074,988	14,316	+3.2%	Shares	Sole	2026-05-04
2025-12-31	$1,097,651	13,875	-0.0%	Shares	Sole	2026-02-09
2025-09-30	$907,898	13,878	-23.4%	Shares	Sole	2025-11-10
2025-06-30	$716,276	18,129	-18.6%	Shares	Sole	2025-07-30
2025-03-31	$672,308	22,284	+31.5%	Shares	Sole	2025-05-01
2024-12-31	$592,292	16,942	+1.6%	Shares	Sole	2025-01-27
2024-09-30	$668,120	16,678	+2.1%	Shares	Sole	2024-10-16
2024-06-30	$778,764	16,340	+0.7%	Shares	Sole	2024-08-12
2024-03-31	$703,527	16,229	+32.6%	Shares	Sole	2024-05-08
2023-12-31	$619,171	12,239	+0.3%	Shares	Sole	2024-01-25
2023-09-30	$553,301	12,198	-2.7%	Shares	Sole	2023-11-14
2023-06-30	$514,434	12,538	+2.4%	Shares	Sole	2023-08-14
2023-03-31	$437,707	12,247	-7.1%	Shares	Sole	2023-05-12
2022-12-31	$497,959	13,184	—	Shares	Sole	2023-02-07
No filing history on record for this holder in this stock.